Sanket Koul

Housing sales slip to 17-quarter low in Q4 2025; launches fall 10%

Housing sales in the top nine cities fell 16% year on year to 98,019 units in Q4 2025, while new launches declined 10%; developers call it a phase of market realignment

Ajanta Pharma signs pact with Biocon to sell semaglutide in 26 countries

Ajanta Pharma has signed an in-licensing pact with Biocon to market semaglutide across 26 countries in Africa, the Middle East and Central Asia, subject to approvals

Education Ministry may consider expanding ONOS scheme to pvt universities

The Union Education Ministry is considering extending the One Nation One Subscription scheme to private higher education institutions, following representations from the private education sector

Bharat Biotech inks tech transfer pact with Biofabri for MTBVAC TB vaccine

Bharat Biotech has signed a technology transfer agreement with Spain's Biofabri to enable end-to-end manufacturing of MTBVAC, with a Phase 3 study in India expected to start recruitment in Q1 2026

Near-term impact on Indian drugmakers unlikely from US pricing policy

Analysts say the US move to link drug prices to the lowest global benchmarks targets patented medicines, limiting near-term risks for India's largely generic-focused exporters

Fortis acquires 125-bed People Tree Hospital in Bengaluru for ₹430 crore

Healthcare chain to invest Rs 840 crore to expand the facility's capacity to 300 beds, eyes over 1500 beds in the city by 2028

Credai's Budget wish list: Revise affordable housing price cap to ₹90 lakh

This comes even as affordable homes have been seeing a drop in demand as well as supply in Tier-I markets such as Delhi NCR and Mumbai

JP Nadda meets Afghan health minister, reiterates medical support

Medical visas, supply of drugs and CT scan machines figure in discussions between both countries

Max to invest over ₹1K cr in 450-bed Pune hospital, eyes West India growth

This will be Max Healthcare's fourth facility in Maharashtra after the 350-bed Nanavati Max Hospital situated in Mumbai and 212-bed Alexis Hospital in Nagpur

Elan Group to invest ₹1,600 cr for ultra luxury housing in Gurugram

The first phase will offer 230 four-bedroom residences across five towers, with unit sizes ranging from around 4,300 to 4,500 square feet

India can be global hub for research, learning with state-led reforms: CEA

India is uniquely placed to benefit from demographics, technology and AI adoption, but state-led reforms under NEP 2020 will determine whether the country can emerge as a global research destination

NMC asks colleges to set up panels to track prescription practices

NMC has asked medical colleges to set up sub-committees to monitor prescription practices and stress clear, legible handwriting as part of medical training.

New higher education regulator won't have funding powers: Pradhan

Lack of clarity on funding of higher education institutes was raised by several experts

Bill to set up single higher education commission tabled, sent to JPC

The introduction of the bill faced sharp resistance from the opposition

IHH plans India expansion after Fortis open offer, to add 2K beds by 2028

Analysts say IHH's play may include improving revenue per bed by lifting clinical mix

Golden Growth Fund deploys ₹58 cr in South Delhi luxury floor projects

Golden Growth Fund said it has deployed Rs 58 crore to acquire two South Delhi projects in Anand Niketan and Niti Bagh for luxury floors, with an estimated sales potential of Rs 85 crore

GLP-1 weight-loss drugs likely to see value growth slowing down

Entry of generics post March 2026, patient dropouts to affect sales values, say experts

With an eye on rivals, Novo Nordisk launches diabetes drug Ozempic in India

With Mounjaro gaining ground, launch comes just three months before Novo loses patent for semaglutide

Novo Nordisk challenges HC order permitting Dr Reddy's semaglutide exports

Novo Nordisk's appeal is listed for hearing on Friday before a bench of Justice C Hari Shankar and Justice Om Prakash Shukla

MPs' forum seeks action on lack of funds for treating rare diseases

A bipartisan parliamentary forum has warned that funding shortages and administrative delays under India's rare disease policy are disrupting life-saving treatment